BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
3.060
-0.040 (-1.29%)
Dec 3, 2024, 1:44 PM EST - Market open
BioVie Market Cap
BioVie has a market cap or net worth of $54.29 million as of December 3, 2024. Its market cap has decreased by -62.74% in one year.
Market Cap
54.29M
Enterprise Value
38.69M
1-Year Change
-62.74%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since September 18, 2020, BioVie's market cap has increased from $52.00M to $54.29M, an increase of 4.40%. That is a compound annual growth rate of 1.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 55.10M | 15.76% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 51.32M |
| vTv Therapeutics | 51.16M |
| Dyadic International | 50.60M |
| AN2 Therapeutics | 49.90M |
| Gain Therapeutics | 49.34M |
| Omega Therapeutics | 48.89M |
| Rallybio | 48.54M |
| Outlook Therapeutics | 48.49M |